More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. to Host Virtual Annual Meeting of Shareholders on November 30, 2018

Medical Marijuana, Inc. to Host Virtual Annual Meeting of Shareholders on November 30, 2018

by adminAdrianRamirez | Nov 29, 2018 | Press Releases

SAN DIEGO, Nov. 29, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, is scheduled to hold its Annual Meeting of Shareholders on Friday, November 30, 2018 at 10:00 a.m. PT on the Internet through a...
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Signs Agreement with National Distributor Mr. Checkout

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Signs Agreement with National Distributor Mr. Checkout

by adminAdrianRamirez | Nov 28, 2018 | Press Releases

SAN DIEGO, Nov. 28, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health has signed an agreement with national distribution leader Mr. Checkout to...
Medical Marijuana, Inc. Announces Q3 2018 as the Largest Revenue Quarter in Company History

Medical Marijuana, Inc. Announces Q3 2018 as the Largest Revenue Quarter in Company History

by adminAdrianRamirez | Nov 27, 2018 | Dixie Botanicals, HempMeds, Kannaway, Press Releases

SAN DIEGO, Nov. 27, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiaries Kannaway®, HempMeds®, HempMeds® Mexico, HempMeds® Brasil, Dixie Botanicals...
Mexico’s COFEPRIS Grants Five New Cannabis Import Permits to Medical Marijuana, Inc. Subsidiary HempMeds® Mexico

Mexico’s COFEPRIS Grants Five New Cannabis Import Permits to Medical Marijuana, Inc. Subsidiary HempMeds® Mexico

by adminAdrianRamirez | Nov 26, 2018 | HempMeds Mexico, Press Releases

SAN DIEGO, Nov. 26, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Mexico has received five new permits from the Mexican Federal Commission for Protection...
Entrepreneur Magazine, Equities, and Daily Mom Include MJNA Portfolio Companies in Their Cannabis Industry Coverage

Entrepreneur Magazine, Equities, and Daily Mom Include MJNA Portfolio Companies in Their Cannabis Industry Coverage

by adminAdrianRamirez | Nov 21, 2018 | HempMeds, Kannaway, Media Coverage

Cannabis events, top CBD products for moms, and investing in the cannabis industry top Medical Marijuana, Inc.’s headlines this week. Medical Marijuana, Inc. and our family of companies continue to be leaders in the cannabis industry, as demonstrated by the inclusion...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.